Revisiones en Cancer Key Metrics
SJR
Q4Oncology
Revisiones en Cancer Journal Specifications
Indexed in the following public directories
- Scopus
Overview | |
Publisher | Aran Ediciones SA |
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Revisiones en Cancer
Role of FDG-PET/CT in diagnosis and follow-up head and neck cancer
- 1 Jan 2024
- Revisiones en Cáncer
Role of radiotherapy in early head and neck cancer
- 1 Jan 2024
- Revisiones en Cáncer
Complications prevention of bone metastases in prostate cancer
- 1 Jan 2024
- Revisiones en Cáncer
Radiotherapy in prostatic cancer
- 1 Jan 2024
- Revisiones en Cáncer
Head and neck carcinoma in patients not eligible for platinum
- 1 Jan 2024
- Revisiones en Cáncer
Role of radiotherapy and re-irradiation in recurrence and metastatic disease
- 1 Jan 2024
- Revisiones en Cáncer
Role of FDG-PET/CT in diagnosis and follow-up head and neck cancer
- 1 Jan 2024
- Revisiones en Cáncer
Role of radiotherapy in early head and neck cancer
- 1 Jan 2024
- Revisiones en Cáncer
Complications prevention of bone metastases in prostate cancer
- 1 Jan 2024
- Revisiones en Cáncer
Radiotherapy in prostatic cancer
- 1 Jan 2024
- Revisiones en Cáncer
Head and neck carcinoma in patients not eligible for platinum
- 1 Jan 2024
- Revisiones en Cáncer
Role of radiotherapy and re-irradiation in recurrence and metastatic disease
- 1 Jan 2024
- Revisiones en Cáncer
FAQs on Revisiones en Cancer
How many articles did Revisiones en Cancer publish last year?
In 2023, Revisiones en Cancer publsihed 28 articles.
What is the SJR for Revisiones en Cancer?
SJR for Revisiones en Cancer is Q4.
Who is the publisher of Revisiones en Cancer?
Aran Ediciones SA is the publisher of Revisiones en Cancer.